JOCELYN DO: Open Payments
NPI 1740724962 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,582 in 69 payments from 12 companies in 2025. Trend: 2023 $615 · 2024 $937 · 2025 $1,582
Food & beverage: $1,483Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $466 |
| Janssen Biotech, Inc. | 17 | $306 |
| Madrigal Pharmaceuticals | 7 | $300 |
| Lilly USA, LLC | 4 | $131 |
| Celltrion USA Inc. | 4 | $81 |
| Gilead Sciences, Inc. | 3 | $80 |
| Ipsen Biopharmaceuticals, Inc | 3 | $77 |
| PFIZER INC. | 2 | $49 |
| Phathom Pharmaceuticals, Inc. | 5 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, OMVOH, RINVOQ, LINZESS, VEGZELMA, IQIRVO.
Industry payments across CA — which companies pay providers there.
